Reporting person on SEC Form 4

Athena Countouriotis

Athena Countouriotis is Director at BioMarin Pharmaceutical. OQRO lists 1 transaction filed with the SEC under this name, the latest on Jun 4, 2026, each linked to the official Form 4.

Director

Disclosures on record

1

Companies involved

1

Disclosure history

BioMarin PharmaceuticalBMRN
Jun 2, 20267,490disclosed Jun 4
Details Official record